CHEMICAL RESEARCH IN TOXICOLOGY OPTIONS

Tirzepatide becoming a twin GLP-one and GIP agonist, it can be advised which the GIP part of dual agonism may be liable for the additional reward, provided the prospective advantage of GIP receptor agonism on peripheral insulin sensitization. As a result, tirzepatide was more effective than dulaglutide in lowering fasting dietary TAG [six,7].three